This work describes a protocol that uses a component-resolved approach to study sensitization to grass pollen allergens in a cohort of patients from southern China with allergic rhinitis and/or asthma.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
* These authors contributed equally
This work describes a protocol that uses a component-resolved approach to study sensitization to grass pollen allergens in a cohort of patients from southern China with allergic rhinitis and/or asthma.
Sensitization to grass pollen imposes a global risk for allergic airway diseases. Although prevention relies on local investigation of the pollen allergens, data on this topic are limited in southern China. Any available data were obtained by self-report questionnaires, skin prick tests, and total or specific IgE tests using crude extracts. For many reasons, these methods are unreliable. Serum sIgE reactivity to Bermuda grass, Timothy grass, and Humulus scandens allergens in a cohort of patients from Greater Guangzhou (southern China's largest city and its outskirts) with allergic rhinitis and/or asthma were examined using a fully-automated immunoassay analyzer as a component-resolved diagnostics (CRD) tool.
For the first time, a considerably high prevalence of Bermuda grass sIgE positivity was demonstrated in Chinese southerners with allergic rhinitis and/or asthma. In these patients, a subtle prevalence of sensitization to Timothy grass and Humulus scandens was also noted, which may arise from cross-reactivity, as the latter two are not common in the region. This was also supported by the detection of allergen components.
Fully-automated immunoassay analyzers may offer satisfactory consistency between regions, laboratories, and institutions and over time. The automaticity of the instrument may enable a standardized detection that would not have been readily revealed before the advent of CRD.
This is a study that uses a CRD approach to investigate sensitization to grass pollen allergens in southern China. It adds to current evidence in the literature. Future studies are needed to validate these findings. However, although CRD is a useful tool, the findings made with the fully-automated immunoassay analyzer should not substitute for other laboratory investigations, clinical evaluations, and physician expertise.
Grass pollen accounts for nearly 50% of immunoglobulin E (IgE)-related allergies and, because of its airborne nature, imposes a global risk of allergic airway diseases, particularly asthma and allergic rhinitis1,2,3,4. Prevention against grass pollen allergies in a region relies on information about the local distribution of the pollen allergens. Unfortunately, the spectrum of the sensitizing allergens varies from place to place—an observation generally known as regional specificity.
In China, a vast East-As....
Access restricted. Please log in or start a trial to view this content.
The study protocol, including human serum sample use, was approved by the Ethics Committee, First Affiliated Hospital of Guangzhou Medical University. All participants offered written informed consent, either independently or via their parents (in the case of children). The protocol has been registered online (Chinese Clinical Trial Registry, Reg No.: ChiCTR-DCC-13004003, refer to http://www.chictr.org/cn/).
1. Identification of the Study Population
NOTE: The Allergy Information Repository of State Key Laboratory of Respiratory Disease (AIR-SKLRD) is the primary source of patient recruitment, because AIR i....
Access restricted. Please log in or start a trial to view this content.
The fully-automated immunoassay analyzer used in this study has a solid-phase structure covered with covalently coupling allergens or allergen components that react with the molecules of interest (sIgE) in serum specimens from the patient. With an automatic program, the analyzer washes off all non-specific IgEs with 150 µL of rinse solution and repeats this 5 times. Then it adds enzyme-labeled anti-IgE antibodies (50 µL) to generate a complex. The enzyme-labeled anti-IgE antibody (conjuga.......
Access restricted. Please log in or start a trial to view this content.
Fully-automated immunoassay analyzers may offer satisfactory consistency between regions, laboratories, and institutions and over time. Such an automatic procedure has been found to substantially support bench research and clinical studies, enable the standardized detection of many allergens and/or allergen components, and identify probable allergen cross-reactivity that would not have been readily revealed before the advent of CRDs. Moreover, the whole testing procedure can be completed with strict quality control, allo.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
We thank Yueming Su for his assistance in preparing the figure. This study was funded by the Guangdong Foundation of Science and Technology (Project No.: 2014A020212352), the Guangzhou Education Bureau (1201630044; 1201630393) and the National Natural Science Foundation of China (NSFC 81572063; NSFC 81601394).
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| ImmunoCAP 1000 Instrument | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 12-3800-01 | |
| Phadia Information Data Manager Software Package | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 12-3801-11 | |
| Software Package, ImmunoCAP 1000 | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 12-3801-12 | |
| g2 (Bermuda grass) | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 14-4131-01 | |
| g6 (Timothy grass) | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 14-4100-01 | |
| w22 (Japanese Hop) | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 14-4452-01 | |
| g216 (nCyn d 1) | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 14-4972-01 | |
| g205 (rPhl p 1) | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 14-5234-01 | |
| g208 (nPhl p 4) | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 14-5288-01 | |
| g215 (rPhl p 5b) | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 14-5338-01 | |
| g209 (rPhl p 6) | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 14-5289-01 | |
| g210 (rPhl p 7) | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 14-5290-01 | |
| g211 (rPhl p 11) | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 14-5291-01 | |
| g212 (rPhl p 12) | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 14-5292-01 | |
| o214 Cross-reacting carbohydrate determinants (CCDs) | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 14-5339-01 | |
| Specific IgE Conjugate 400 | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 10-9310-08 | |
| Specific IgE Calibrator Strip | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 10-9459-08 | |
| Specific IgE Curve Control Strip | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 10-9312-08 | |
| Specific IgE Anti-IgE ImmunoCAP | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 14-4417-01 | |
| ImmunoCAP Specific IgE Negative Control | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 10-9445-01 | |
| ImmunoCAP Specific IgE Control L | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 10-9528-01 | |
| ImmunoCAP Specific IgE Control M | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 10-9529-01 | |
| ImmunoCAP Specific IgE Control H | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 10-9530-01 | |
| Development Solution | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 10-9439-08 | |
| Stop Solution | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 34-2271-58 | |
| Washing Solution | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 10-9202-08 | |
| FluoroC | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 10-9264-01 | |
| Maintenance Solution Kit | Thermo Fisher Scientific Inc.(Phadia AB, Uppsala Sweden) | 10-9476-01 |
Access restricted. Please log in or start a trial to view this content.